The Breast Cancer Program of the Abramson Cancer Center (ACC) was formally established in 1994 and has been continuously approved by the NCI since 1999. The Program is currently led by Angela DeMichele, MD, MSCE, an expert in clinical trials and translational biomarker research who has served as a Co-Leader since 2005, and Roger Greenberg, MD, PhD, who has a complementary background in breast cancer biology (focusing on BRCA-dependent DNA repair) and genetic susceptibility. Dr. Greenberg recently replaced Dr. Chodosh, the ACC's AD for Basic Research, who continues to be an active member. Members of the Program are focused on understanding the underlying causes of breast cancer to improve the detection, prevention, and treatment of this disease. They work together to achieve this goal by focusing on four key scientific areas: 1) Elucidation of the genetic and molecular mechanisms of breast cancer development and progression; 2) Improvements in genetic risk assessment and development of novel prevention strategies; 3) Development of innovative imaging approaches to improve breast cancer detection and the assessment of therapeutic response; and 4) Translation of laboratory discoveries to novel therapeutics and biomarkers of response and outcome. Members are highly interactive, as reflected in their leadership of multiple collaborative grants, including an NCI U01, an NCI U54, a Department of Defense (DOD) Breast Cancer Center of Excellence, a DOD Idea Award, the Basser Center for BRCA, the 2-PREVENT Breast Cancer Translational Center of Excellence and numerous interdisciplinary translational clinical trials. In addition to facilitating intra- and inter- Programmatic collaborations, Program Leadership has emphasized breast cancer translational research as a major focus, implementing a breast cancer biospecimen bank and database, recruiting external faculty with important new expertise to the Program, and holding or participating in major ACC retreats that emphasize breast cancer research. The ACC's investment in clinical research, particularly the interdisciplinary Rena Rowan Breast Center, has facilitated patient-oriented research. The Program consists of 19 members from eight departments in the Perelman School of Medicine and the School of Arts and Sciences. These members have $9M in cancer-related grant funding (annual direct costs), of which $7.5M is peer-reviewed and $4.6M is NCI-funded. During the current project period, members published 316 cancer-related papers, of which 9% were the result of intra-Programmatic collaborations, 51% were the result of inter-Programmatic collaborations, and 34% were multi-institutional.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-41
Application #
9359393
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Marino, Michael A
Project Start
Project End
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
41
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Liu, Wei; Krump, Nathan A; MacDonald, Margo et al. (2018) Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts. J Virol 92:
Schapira, Marilyn M; Barlow, William E; Conant, Emily F et al. (2018) Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol 25:1118-1127
Morrison, Alexander H; Byrne, Katelyn T; Vonderheide, Robert H (2018) Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 4:418-428
Ojha, Rani; Leli, Nektaria M; Onorati, Angelique et al. (2018) ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discov :
Yan, Lesan; Amirshaghaghi, Ahmad; Huang, Dennis et al. (2018) Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy. Adv Funct Mater 28:
Waxman, Adam J; Clasen, Suparna; Hwang, Wei-Ting et al. (2018) Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 4:e174519
Han, Joseph; Lachance, Catherine; Ricketts, M Daniel et al. (2018) The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate. J Biol Chem 293:4498-4509
Reshef, Ran; Ganetsky, Alex; Acosta, Edward P et al. (2018) Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biol Blood Marrow Transplant :
Gangadhar, Tara C; Savitch, Samantha L; Yee, Stephanie S et al. (2018) Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. Pigment Cell Melanoma Res 31:73-81
Rosenfeld, Aaron M; Meng, Wenzhao; Luning Prak, Eline T et al. (2018) ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data. Front Immunol 9:2107

Showing the most recent 10 out of 1047 publications